There are various studies demonstrating the relationship between inflammation and development of various solid cancers, including gynecological cancer. It is believed that oncological outcomes can be predicted through this concept (Chun et al., 2017
Conditions
Interventions
Participants who had Recurrence CIN within 2 years after LEEP,Participants who had non-Recurrence CIN within 2 years after LEEP
Prevention,Prevention
Recurrence CIN,Non-Recurrence CIN
Sponsors
Department of Obstetrics and Gynecology, Faculty of Medicine, Bhumibol Adulyadej Hospital, Bangkok, Thailand
Eligibility
Sex/Gender
Female
Inclusion criteria
Inclusion criteria: Data was collected from medical records of patients from year 2016 to 2021. Inclusion criteria were patients who underwent LEEP of all CIN types with pathologic confirmation with followed up visits up to two years (at 6 months, 1 and 2 years). Preoperative hematological values were obtained within one month prior of LEEP procedure including CBC to calculate as systemic inflammatory values. NLR, PLR and MLR, SIRI, SII, and AISI
Exclusion criteria
Exclusion criteria: The exclusion criteria were incomplete data collection, loss or incomplete follow up, underwent hysterectomy due to no free margin and cervical cancer followed by LEEP procedure.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Recurrence CIN within 2 years after LEEP mean | — |
Secondary
| Measure | Time frame |
|---|---|
| Cut off values of inflammatory markers within 2 years after LEEP mean | — |
Countries
Thailand
Contacts
Public ContactSamornrat Bunpreenant
Bhumibol Adulyadej Hospital, Bangkok, Thailand
Outcome results
None listed